145 related articles for article (PubMed ID: 23791075)
1. Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Aug; 154(3-4):153-9. PubMed ID: 23791075
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of tyrosine-kinase receptor c-KIT (c-KIT) mutations, mRNA and protein expression in canine leukemia: might c-KIT represent a therapeutic target?
Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Martini V; Comazzi S; Dacasto M
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):325-32. PubMed ID: 23375718
[TBL] [Abstract][Full Text] [Related]
3. KIT gene exon 11 mutations in canine malignant melanoma.
Chu PY; Pan SL; Liu CH; Lee J; Yeh LS; Liao AT
Vet J; 2013 May; 196(2):226-30. PubMed ID: 23069279
[TBL] [Abstract][Full Text] [Related]
4. Aberrant phenotypes and quantitative antigen expression in different subtypes of canine lymphoma by flow cytometry.
Gelain ME; Mazzilli M; Riondato F; Marconato L; Comazzi S
Vet Immunol Immunopathol; 2008 Feb; 121(3-4):179-88. PubMed ID: 17981339
[TBL] [Abstract][Full Text] [Related]
5. Identification of altered MicroRNA expression in canine lymphoid cell lines and cases of B- and T-Cell lymphomas.
Uhl E; Krimer P; Schliekelman P; Tompkins SM; Suter S
Genes Chromosomes Cancer; 2011 Nov; 50(11):950-67. PubMed ID: 21910161
[TBL] [Abstract][Full Text] [Related]
6. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
[TBL] [Abstract][Full Text] [Related]
7. Aberrant autophosphorylation of c-Kit receptor in canine mast cell tumor cell lines.
Takeuchi Y; Fujino Y; Watanabe M; Nakagawa T; Ohno K; Sasaki N; Sugano S; Tsujimoto H
Vet Immunol Immunopathol; 2010 Oct; 137(3-4):208-16. PubMed ID: 20591500
[TBL] [Abstract][Full Text] [Related]
8. COX-2 and c-kit expression in canine gliomas.
Jankovsky JM; Newkirk KM; Ilha MR; Newman SJ
Vet Comp Oncol; 2013 Mar; 11(1):63-9. PubMed ID: 22235799
[TBL] [Abstract][Full Text] [Related]
9. The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study.
Aricò A; Giantin M; Gelain ME; Riondato F; Comazzi S; Rütgen BC; Essler SE; Dacasto M; Castagnaro M; Aresu L
BMC Vet Res; 2013 May; 9():94. PubMed ID: 23641796
[TBL] [Abstract][Full Text] [Related]
10. Transferrin receptor expression in canine lymphoma.
Priest H; McDonough S; Erb H; Daddona J; Stokol T
Vet Pathol; 2011 Mar; 48(2):466-74. PubMed ID: 20685917
[TBL] [Abstract][Full Text] [Related]
11. Identification of c-kit mutations-independent neoplastic cell proliferation of canine mast cells.
Ohmori K; Kawarai S; Yasuda N; Tanaka A; Matsuda H; Nishimura R; Sasaki N; Tsujimoto H; Masuda K
Vet Immunol Immunopathol; 2008 Nov; 126(1-2):43-53. PubMed ID: 18687474
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the p16 cyclin-dependent kinase inhibitor in high-grade canine non-Hodgkin's T-cell lymphoma.
Fosmire SP; Thomas R; Jubala CM; Wojcieszyn JW; Valli VE; Getzy DM; Smith TL; Gardner LA; Ritt MG; Bell JS; Freeman KP; Greenfield BE; Lana SE; Kisseberth WC; Helfand SC; Cutter GR; Breen M; Modiano JF
Vet Pathol; 2007 Jul; 44(4):467-78. PubMed ID: 17606508
[TBL] [Abstract][Full Text] [Related]
13. Specific c-kit mutations in sinonasal natural killer/T-cell lymphoma in China and Japan.
Hongyo T; Li T; Syaifudin M; Baskar R; Ikeda H; Kanakura Y; Aozasa K; Nomura T
Cancer Res; 2000 May; 60(9):2345-7. PubMed ID: 10811105
[TBL] [Abstract][Full Text] [Related]
14. Checkpoint molecule expression by B and T cell lymphomas in dogs.
Hartley G; Elmslie R; Dow S; Guth A
Vet Comp Oncol; 2018 Sep; 16(3):352-360. PubMed ID: 29380929
[TBL] [Abstract][Full Text] [Related]
15. Retrospective study of 82 cases of canine lymphoma in Austria based on the Working Formulation and immunophenotyping.
Guija de Arespacochaga A; Schwendenwein I; Weissenböck H
J Comp Pathol; 2007; 136(2-3):186-92. PubMed ID: 17416237
[TBL] [Abstract][Full Text] [Related]
16. Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma.
Poggi A; Miniscalco B; Morello E; Comazzi S; Gelain ME; Aresu L; Riondato F
Vet Comp Oncol; 2015 Dec; 13(4):475-80. PubMed ID: 24341365
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the prognostic significance of BCL6 gene expression in canine high-grade B-cell lymphoma.
Sato M; Kanemoto H; Kagawa Y; Kobayashi T; Goto-Koshino Y; Mochizuki H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
Vet J; 2012 Jan; 191(1):108-14. PubMed ID: 21277811
[TBL] [Abstract][Full Text] [Related]
18. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
[TBL] [Abstract][Full Text] [Related]
19. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
Usher SG; Radford AD; Villiers EJ; Blackwood L
Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
[TBL] [Abstract][Full Text] [Related]
20. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
